Short answer · Medically reviewed summary · Last updated: 2026-04-07

Menkes disease is a rare, life-limiting genetic disorder that impairs the body’s ability to transport copper, leading to severe neurological decline and connective tissue abnormalities. Caused by mutations in the ATP7A gene, it typically presents in infancy and requires specialized, multidisciplinary management to address its complex physiological impacts. What is the underlying cause of Menkes disease? Menkes disease is an X-linked recessive disorder caused by mutations in the ATP7A gene.

What is Menkes Disease

Name: What is Menkes Disease
Creator: DiseaseMaps Editorial Team
Published: 2015-07-16UTC15:56:52.0000000

What is Menkes Disease? Plain-language, medically reviewed definition plus the lived reality told by patients.

Menkes disease is a rare, life-limiting genetic disorder that impairs the body’s ability to transport copper, leading to severe neurological decline and connective tissue abnormalities. Caused by mutations in the ATP7A gene, it typically presents in infancy and requires specialized, multidisciplinary management to address its complex physiological impacts.

What is the underlying cause of Menkes disease?

Menkes disease is an X-linked recessive disorder caused by mutations in the ATP7A gene. This gene is responsible for providing instructions to make a protein that transports copper throughout the body. Because copper is an essential mineral for the function of various enzymes—including those required for brain development, bone health, and the integrity of blood vessels—a deficiency in this transport mechanism leads to the systemic symptoms seen in Menkes disease. When copper cannot reach the tissues that need it, the body is unable to produce healthy collagen, elastin, and neurotransmitters, resulting in the characteristic clinical features of the condition.

How does Menkes disease affect the body?

Because copper is vital for so many biological processes, Menkes disease affects multiple body systems simultaneously. The most prominent symptoms usually appear within the first few months of life. Common clinical observations include:

Neurological symptoms: Developmental delay, intellectual disability, seizures, and hypotonia (floppy muscle tone).

Physical traits: Sparse, brittle, or "kinky" hair that is often colorless or light-colored, and characteristic facial features such as sagging cheeks.

Connective tissue issues: Weakened blood vessels, which can lead to internal bleeding or blockages, and skeletal changes, including bone fractures or joint laxity.

Gastrointestinal symptoms: Difficulty feeding and failure to thrive are common in infants diagnosed with Menkes disease.

How common is Menkes disease and who is affected?

Menkes disease is exceptionally rare, with an estimated prevalence ranging from 1 in 100,000 to 1 in 250,000 live births globally. Because the condition is X-linked, it primarily affects males. Female carriers of the ATP7A mutation typically do not show symptoms, though they have a 50% chance of passing the mutation to their sons. There are no specific geographic or ethnic predispositions, as Menkes disease has been identified in populations worldwide. Within the DiseaseMaps.org community, 74 people have joined to share their experiences and navigate the challenges of this rare diagnosis.

Are there different forms of this condition?

While Menkes disease is the classic, severe presentation, there is a clinical spectrum of ATP7A-related disorders. At the milder end of this spectrum is Occipital Horn Syndrome (OHS), which features similar connective tissue issues but significantly less severe neurological involvement. Additionally, some individuals may present with intermediate forms that show milder symptoms than the classic, rapid-progression form of Menkes disease.

Next steps

Consult a metabolic geneticist or a pediatric neurologist to confirm a diagnosis through genetic testing and copper/ceruloplasmin blood panels.

Connect with the 74 members of the DiseaseMaps.org community to share resources and emotional support.

Inquire with your care team about potential access to early copper-histidine therapy, which may be beneficial if initiated very early in the disease course.

Reach out to organizations like the Menkes Foundation for disease-specific educational materials and clinical trial information.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult with a qualified healthcare professional regarding any medical concerns or treatment decisions.